logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Cure Vac Appoints Axel Sven Malkomes As Chief Financial Officer

Nov 04, 2024•about 1 year ago

Position

Chief Financial Officer

Company

CureVac

Axel Sven Malkomes
TübingenBiotechnologyHealth Care

Description

CureVac appoints Axel Sven Malkomes as the new Chief Financial Officer, leveraging his extensive senior corporate and investment banking experience in the biotech and pharmaceutical industries.

Company Information

Company

CureVac

Location

Tübingen, Baden-Württemberg, Germany

About

CureVac is a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA) for the prevention and treatment of a range of infectious diseases, cancer and rare diseases. The company is pioneering the use of natural and chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months